Estimating the societal costs and benefits of de-implementation of low-value care: developing a modelling approach through case assessment

Previous estimates of potential costs savings from de-implementation of low-value care have been calculated with simple modelling approaches, focused on direct medical costs and did not take substitution into account. Therefore, the aim of this study was to develop and evaluate a modelling approach to calculate a more realistic estimate of societal costs and benefits of de-implementation of low-value care. The modelling approach was developed and evaluated in three steps: (1) review of reviews to identify aspects that may affect the costs and benefits of de-implementation, (2) selection of three cases of low-value care, (3) development and evaluation of the modelling approach for each case. Desk research and interviews with actors were used in step 3 to define input parameters. The modelling approach was build and evaluated for the following cases: (1) surgery for achilles tendon rupture, (2) mammography for women < 30 years with focal breast complaints, and (3) imaging for non-specific low back pain. From the interviews, it appeared that case 2 had already been fully disinvested. Hence, calculating the societal costs and benefits for this case was not considered valuable. For case 1 and 3 it was considered valuable and feasible to calculate the societal costs and benefits. Compared to the adapted societal business case approach used in case 1, the adapted societal cost-benefit analysis approach used for case 3 provided a more realistic and better estimate. It is feasible to calculate a more elaborate and realistic estimate of societal costs and benefits of the de-implementation of low-value care than previous estimates. Nevertheless, it was not feasible to include the costs of de-implementation itself as these are highly reliant on the specific de-implementation strategy employed, which is context specific. Furthermore, the time needed to calculate a more elaborate and realistic estimate stresses the need to carefully select low-value care cases for which the value of calculating such an elaborate and realistic estimate outweighs the effort required to do so.

Authors

Institutions

Publication Details

Journal
BMC Health Services Research
Published
2025-06-02
DOI
https://doi.org/10.1186/s12913-025-12948-7
Primary Topic
Healthcare cost, quality, practices
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Estimating the societal costs and benefits of de-implementation of low-value care: developing a modelling approach through case assessment

M Rodriguez, Peter Paul F Klein, Marleen E. Jansen, Adriënne H. Rotteveel et al.
4 links
BMC Health Services Research
Healthcare cost, quality, practices
article

Estimating the societal costs and benefits of de-implementation of low-value care: developing a modelling approach through case assessment

M Rodriguez, Peter Paul F Klein, Marleen E. Jansen, Adriënne H. Rotteveel, Meike M Klaassen
article en

Abstract

Previous estimates of potential costs savings from de-implementation of low-value care have been calculated with simple modelling approaches, focused on direct medical costs and did not take substitution into account. Therefore, the aim of this study was to develop and evaluate a modelling approach to calculate a more realistic estimate of societal costs and benefits of de-implementation of low-value care. The modelling approach was developed and evaluated in three steps: (1) review of reviews to identify aspects that may affect the costs and benefits of de-implementation, (2) selection of three cases of low-value care, (3) development and evaluation of the modelling approach for each case. Desk research and interviews with actors were used in step 3 to define input parameters. The modelling approach was build and evaluated for the following cases: (1) surgery for achilles tendon rupture, (2) mammography for women < 30 years with focal breast complaints, and (3) imaging for non-specific low back pain. From the interviews, it appeared that case 2 had already been fully disinvested. Hence, calculating the societal costs and benefits for this case was not considered valuable. For case 1 and 3 it was considered valuable and feasible to calculate the societal costs and benefits. Compared to the adapted societal business case approach used in case 1, the adapted societal cost-benefit analysis approach used for case 3 provided a more realistic and better estimate. It is feasible to calculate a more elaborate and realistic estimate of societal costs and benefits of the de-implementation of low-value care than previous estimates. Nevertheless, it was not feasible to include the costs of de-implementation itself as these are highly reliant on the specific de-implementation strategy employed, which is context specific. Furthermore, the time needed to calculate a more elaborate and realistic estimate stresses the need to carefully select low-value care cases for which the value of calculating such an elaborate and realistic estimate outweighs the effort required to do so.

BMC Health Services ResearchVol. 25(1)
National Institute for Public Health and the Environment (NL)
Rijksinstituut voor Volksgezondheid en Milieu
Partnerships for the goals
Openalex Percentile: Top 79%
Healthcare cost, quality, practices
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.